AGP
PFE icon

Aspire Growth Partners’s Pfizer PFE Stock Holding History

Aspire Growth Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Sell
16,975
-617
-4% -$16.1K 0.24% 80
2026
Q1 		$494K Sell
17,592
-1,496
-8% -$39.8K 0.34% 66
2025
Q4 		$475K Sell
19,088
-1,448
-7% -$36.5K 0.33% 71
2025
Q3 		$523K Sell
20,536
-2,398
-10% -$59.2K 0.38% 62
2025
Q2 		$556K Buy
22,934
+601
+3% +$14K 0.46% 53
2025
Q1 		$509K Hold
22,333
– – 0.45% 60
2024
Q4 		$592K Buy
+22,333
New +$606K 0.58% 44

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Aspire Growth Partners's PFE Position: Q2 2026 in Review

Aspire Growth Partners reduced its Pfizer (PFE) stake by 3.5% in Q2 2026, selling an estimated $16.1K and leaving 16,975 shares worth $409K. The position accounts for 0.24% of the portfolio, ranked #80.

Aspire Growth Partners first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $592K in Q4 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Aspire Growth Partners held 16,975 shares of Pfizer worth $409K as of Q2 2026.
  • Aspire Growth Partners sold 617 Pfizer shares in Q2 2026, an estimated $16.1K.
  • Pfizer made up 0.24% of Aspire Growth Partners's portfolio in Q2 2026, its #80 holding.
  • Aspire Growth Partners first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Aspire Growth Partners's Pfizer position peaked at $592K in Q4 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Aspire Growth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.